Metadon Dak (Methadone Hydrochloride)

Methadone Hydrochloride is used in the management of opioid‑related conditions and pain syndromes.

• Opioid dependence: helps suppress withdrawal symptoms and supports long‑term abstinence.
• Moderate to severe pain: provides effective analgesia for chronic or acute pain when other treatments are insufficient.
• Opioid use disorder: stabilises patients during maintenance therapy and reduces illicit opioid use.

• Methadone Hydrochloride acts as a full agonist at the mu‑opioid receptors in the central nervous system. By binding these receptors, it inhibits the transmission of nociceptive signals and reduces neuronal excitability, thereby diminishing the perception of pain and alleviating withdrawal symptoms associated with opioid dependence.

Methadone Hydrochloride may cause a range of adverse reactions, from mild to severe.

Common Side Effects

• Nausea: occasional upset stomach or vomiting.
• Constipation: reduced bowel movements, often requiring dietary adjustments.
• Drowsiness: increased sleepiness or fatigue.
• Sweating: excessive perspiration, especially at night.
• Dry mouth: reduced salivation leading to discomfort.
• Dizziness: feeling light‑headed or unsteady.

Serious or Rare Side Effects

• Respiratory depression: slowed breathing that can be life‑threatening.
• QT interval prolongation: cardiac rhythm disturbance that may cause arrhythmia.
• Seizures: rare episodes of convulsive activity.
• Severe hypotension: marked drop in blood pressure.
• Allergic reactions: rash, itching, swelling, or anaphylaxis.
• Adrenal insufficiency: rare hormonal imbalance affecting stress response.

When prescribing or dispensing Methadone Hydrochloride, several safety considerations are essential.

• Assess tolerance: confirm patient’s opioid tolerance before initiating therapy.
• Monitor respiration: observe breathing rate, especially during dose adjustments.
• Cardiac evaluation: check baseline ECG for QT prolongation risk.
• Hepatic function: adjust dosing in patients with liver impairment.
• Avoid abrupt discontinuation: taper gradually to prevent withdrawal.
• Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Methadone Hydrochloride can interact with a variety of medicines, influencing its safety and efficacy.

Major Interactions (Avoid)

• CNS depressants (e.g., benzodiazepines, alcohol): may cause profound respiratory depression.
• MAO inhibitors: increase risk of serotonin syndrome and hypertensive crisis.
• QT‑prolonging drugs (e.g., antiarrhythmics, certain antibiotics): heighten arrhythmia risk.
• Strong CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): raise methadone plasma levels.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., rifampin, carbamazepine): may reduce methadone effectiveness.
• Other opioids: additive sedation and respiratory effects.
• Certain antidepressants (e.g., SSRIs, SNRIs): may alter methadone metabolism.
• Antihistamines: can increase drowsiness and dizziness.